FR2100839B1 - - Google Patents
Info
- Publication number
- FR2100839B1 FR2100839B1 FR7123583A FR7123583A FR2100839B1 FR 2100839 B1 FR2100839 B1 FR 2100839B1 FR 7123583 A FR7123583 A FR 7123583A FR 7123583 A FR7123583 A FR 7123583A FR 2100839 B1 FR2100839 B1 FR 2100839B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5750770 | 1970-06-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2100839A1 FR2100839A1 (US20100223739A1-20100909-C00025.png) | 1972-03-24 |
| FR2100839B1 true FR2100839B1 (US20100223739A1-20100909-C00025.png) | 1974-09-06 |
Family
ID=13057634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7123583A Expired FR2100839B1 (US20100223739A1-20100909-C00025.png) | 1970-06-30 | 1971-06-29 |
Country Status (8)
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3922261A (en) * | 1972-06-21 | 1975-11-25 | Merck Patent Gmbh | Adenosine derivative |
| US5565566A (en) * | 1987-04-24 | 1996-10-15 | Discovery Therapeutics, Inc. | N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| US5066655A (en) * | 1987-04-24 | 1991-11-19 | Whitby Research, Inc. | N6-substituted 9-methyladenines: a new class of adenosine receptor antagonists |
| US5155098A (en) * | 1989-06-09 | 1992-10-13 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines, and pharmaceutical compositions and methods employing them |
| US5017578A (en) * | 1989-06-09 | 1991-05-21 | Hoechst-Roussel Pharmaceuticals Inc. | N-heteroaryl-purin-6-amines useful as analgesic and anticonvulsant agents |
| DK0550631T3 (da) * | 1990-09-25 | 1997-01-20 | Rhone Poulenc Rorer Int | Forbindelser med blodtrykssænkende virkning og virkning mod iskæmi |
| US5561134A (en) * | 1990-09-25 | 1996-10-01 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| US5432164A (en) * | 1991-10-24 | 1995-07-11 | Novo Nordisk A/S | C2,N6 -disubstituted adenosine derivatives |
| DK62592D0 (US20100223739A1-20100909-C00025.png) * | 1992-05-14 | 1992-05-14 | Novo Nordisk As | |
| TW528755B (en) | 1996-12-24 | 2003-04-21 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| YU44900A (sh) | 1998-01-31 | 2003-01-31 | Glaxo Group Limited | Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola |
| ATE246701T1 (de) | 1998-06-23 | 2003-08-15 | Glaxo Group Ltd | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivate |
| US7205404B1 (en) * | 1999-03-05 | 2007-04-17 | Metabasis Therapeutics, Inc. | Phosphorus-containing prodrugs |
| JP4979866B2 (ja) * | 1999-09-08 | 2012-07-18 | リガンド・ファーマシューティカルズ・インコーポレイテッド | 肝臓に特異的なドラッグデリバリーのためのプロドラッグ |
| AR049384A1 (es) * | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | Derivados de purina |
| GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
| JP2017512183A (ja) | 2014-02-13 | 2017-05-18 | リガンド・ファーマシューティカルズ・インコーポレイテッド | プロドラッグ化合物およびそれらの使用 |
| EP3164136A4 (en) | 2014-07-02 | 2018-04-04 | Ligand Pharmaceuticals, Inc. | Prodrug compounds and uses therof |
| JP2021509907A (ja) | 2018-01-09 | 2021-04-08 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アセタール化合物およびその治療的使用 |
-
1971
- 1971-06-23 US US00156138A patent/US3796700A/en not_active Expired - Lifetime
- 1971-06-23 BE BE768925A patent/BE768925A/xx unknown
- 1971-06-25 NL NL7108858A patent/NL7108858A/xx unknown
- 1971-06-26 DE DE19712131938 patent/DE2131938A1/de active Pending
- 1971-06-28 GB GB3012371A patent/GB1351501A/en not_active Expired
- 1971-06-29 FR FR7123583A patent/FR2100839B1/fr not_active Expired
- 1971-06-29 HU HUTA1126A patent/HU163640B/hu unknown
- 1971-06-30 CA CA117,084A patent/CA954856A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| HU163640B (US20100223739A1-20100909-C00025.png) | 1973-09-27 |
| CA954856A (en) | 1974-09-17 |
| BE768925A (fr) | 1971-11-03 |
| US3796700A (en) | 1974-03-12 |
| DE2131938A1 (de) | 1972-01-05 |
| FR2100839A1 (US20100223739A1-20100909-C00025.png) | 1972-03-24 |
| NL7108858A (US20100223739A1-20100909-C00025.png) | 1972-01-03 |
| GB1351501A (en) | 1974-05-01 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |